Ausgabe 2/2008
Inhalt (9 Artikel)
Targeted agents in gastrointestinal cancer: a reality in clinical practice
Eric Van Cutsem
Rationale for targeted therapies in hepatocellular carcinoma
Sandrine Faivre, Chantal Dreyer, Ghassan El Maalouf, Marie-Paule Sablin, Eric Raymond
Can we predict the response to epidermal growth factor receptor targeted therapy?
Philipp C. Manegold, Georg Lurje, Alexandra Pohl, Yan Ning, Wu Zhang, Heinz-Josef Lenz
Imaging and targeted agents in gastrointestinal cancers: overview on perfusion- and diffusion-weighted magnetic resonance imaging and angiogenesis inhibitors
Vincent Vandecaveye, Frederik De Keyzer, Steven Dymarkowski
A new functional imaging technique for the early functional evaluation of antiangiogenic treatment: dynamic contrast-enhanced ultrasonography (DCE-US)
Nathalie Lassau, Mohamed Chebil, Linda Chami, Alain Roche
Targeted therapies and surgical issues in gastrointestinal cancers
Alexander A. Parikh, Lee M. Ellis
Controversial evaluation of EGFR protein and gene status in predicting response to anti-EGFR monoclonal antibodies in metastatic colorectal cancer: a case report and review of the literature
Mauro Moroni, Silvio Veronese, Andrea Sartore-Bianchi, Salvatore Artale, Salvatore Siena